from Reuters: Health News https://reut.rs/2IUZsur
Thursday, May 2, 2019
Thursday, May 02, 2019
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Novartis's Sandoz division has struck a deal with Taiwan's EirGenix Inc to market a biosimilar version of Roche's Herceptin that is now in late-stage development to treat some cancer tumors.

from Reuters: Health News https://reut.rs/2IUZsur
from Reuters: Health News https://reut.rs/2IUZsur
Related Posts:
LATEST HEALTH NEWSFour large drug companies could resume talks on Tuesday to try to reach a $48 billion settlement of all opioid litigation against them, after agreeing with two Ohio counties to a $260 million deal to avert the first federal t… Read More
LATEST HEALTH NEWSA Los Angeles County resident has died from a lung illness possibly tied to vaping, bringing the total number of such U.S. deaths to five, health officials said on Friday. from Reuters: Health News https://ift.tt/312bwiL… Read More
LATEST HEALTH NEWSTBILISI - City dwellers tend to live longer if they are in leafy neighborhoods, according to a study published on Wednesday that linked green areas to lower rates of premature death. from Reuters: Health News https://ift… Read More
LATEST HEALTH NEWSVenezuelan migrants will be provided with a regional vaccination card beginning in October, health officials from 10 countries agreed on Monday, in an effort to ensure they receive needed vaccines and are not given double dos… Read More
LATEST HEALTH NEWSShares of Australia's biggest listed aged care providers fell on Friday after a government-backed inquiry strongly criticized care of the elderly and vulnerable, raising expectations of a far-reaching regulatory overhaul. … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment